Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Ended earlyNCT01122901
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 47
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Very early researchActive Not RecruitingNCT06824662
What this trial is testing

Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas

Who this might be right for
Glioblastoma WHO Grade IV
Nader Sanai 30
Early research (Phase 1)Active Not RecruitingNCT02208362
What this trial is testing

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Recurrent GlioblastomaRecurrent Malignant GliomaRecurrent WHO Grade II Glioma+5 more
City of Hope Medical Center 65
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT02149459
What this trial is testing

Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy

Who this might be right for
Brain Neoplasms
Sheba Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT06264388
What this trial is testing

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Who this might be right for
High Grade GliomaAnaplastic Astrocytoma
Ashish Shah 33
Early research (Phase 1)Looking for participantsNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Early research (Phase 1)Looking for participantsNCT07193628
What this trial is testing

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

Who this might be right for
Refractory GlioblastomaRecurrent Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 14
Large-scale testing (Phase 3)WithdrawnNCT01830101
What this trial is testing

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
AHS Cancer Control Alberta
Large-scale testing (Phase 3)Study completedNCT02511405
What this trial is testing

A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)

Who this might be right for
Glioblastoma
Vascular Biogenics Ltd. operating as VBL Therapeutics 252
Testing effectiveness (Phase 2)Study completedNCT01301430
What this trial is testing

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Who this might be right for
Glioblastoma Multiforme
Oryx GmbH & Co. KG 18
Testing effectiveness (Phase 2)Ended earlyNCT00479765
What this trial is testing

/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Who this might be right for
Glioblastoma MultiformeBrain Neoplasms
Boston Scientific Corporation 4
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00093964
What this trial is testing

Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

Who this might be right for
Glioblastoma Multiforme
EMD Serono 81
Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Testing effectiveness (Phase 2)Ended earlyNCT00062504
What this trial is testing

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Teva Branded Pharmaceutical Products R&D, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00038493
What this trial is testing

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT07093814
What this trial is testing

VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Who this might be right for
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd. 42
Next Page